Thrivent Financial for Lutherans’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $88.2M | Buy |
1,620,743
+52,116
| +3% | +$2.54M | 0.15% | 159 |
|
|
2026
Q1 | $67.3M | Buy |
1,568,627
+380,522
| +32% | +$16.4M | 0.13% | 186 |
|
|
2025
Q4 | $52.1M | Buy |
1,188,105
+1,126,256
| +1,821% | +$46.6M | 0.09% | 267 |
|
|
2025
Q3 | $2.55M | Sell |
61,849
-7,241
| -10% | -$291K | 0.01% | 1190 |
|
|
2025
Q2 | $3.04M | Sell |
69,090
-57
| -0.1% | -$2.28K | 0.01% | 1079 |
|
|
2025
Q1 | $2.55M | Sell |
69,147
-5,086
| -7% | -$181K | 0.01% | 1125 |
|
|
2024
Q4 | $2.47M | Sell |
74,233
-1,451
| -2% | -$47.1K | ﹤0.01% | 1287 |
|
|
2024
Q3 | $1.96M | Sell |
75,684
-3,367
| -4% | -$83.7K | ﹤0.01% | 1460 |
|
|
2024
Q2 | $1.78M | Sell |
79,051
-130,323
| -62% | -$2.89M | ﹤0.01% | 1458 |
|
|
2024
Q1 | $4.97M | Sell |
209,374
-33,082
| -14% | -$735K | 0.01% | 898 |
|
|
2023
Q4 | $5.82M | Buy |
242,456
+70,136
| +41% | +$1.52M | 0.01% | 800 |
|
|
2023
Q3 | $3.77M | Buy |
172,320
+88,270
| +105% | +$1.85M | 0.01% | 919 |
|
|
2023
Q2 | $1.61M | Sell |
84,050
-1,479
| -2% | -$28.5K | ﹤0.01% | 1483 |
|
|
2023
Q1 | $1.66M | Sell |
85,529
-389
| -0.5% | -$6.78K | ﹤0.01% | 1419 |
|
|
2022
Q4 | $1.38M | Sell |
85,918
-42,036
| -33% | -$686K | ﹤0.01% | 1523 |
|
|
2022
Q3 | $2.01M | Buy |
127,954
+43,807
| +52% | +$846K | 0.01% | 1215 |
|
|
2022
Q2 | $1.75M | Buy |
84,147
+1,470
| +2% | +$30.3K | ﹤0.01% | 1313 |
|
|
2022
Q1 | $1.87M | Sell |
82,677
-748
| -0.9% | -$14.6K | ﹤0.01% | 1369 |
|
|
2021
Q4 | $1.52M | Buy |
83,425
+1,075
| +1% | +$20.6K | ﹤0.01% | 1583 |
|
|
2021
Q3 | $1.74M | Sell |
82,350
-843
| -1% | -$15.7K | ﹤0.01% | 1446 |
|
|
2021
Q2 | $1.52M | Buy |
83,193
+251
| +0.3% | +$5.85K | ﹤0.01% | 1596 |
|
|
2021
Q1 | $1.87M | Buy |
82,942
+1,716
| +2% | +$38.8K | ﹤0.01% | 1466 |
|
|
2020
Q4 | $1.63M | Sell |
81,226
-1,995
| -2% | -$41.8K | ﹤0.01% | 1447 |
|
|
2020
Q3 | $2.04M | Sell |
83,221
-1,491
| -2% | -$34.8K | 0.01% | 1146 |
|
|
2020
Q2 | $2.01M | Buy |
84,712
+5,319
| +7% | +$123K | 0.01% | 1057 |
|
|
2020
Q1 | $1.37M | Hold |
79,393
| – | – | ﹤0.01% | 1130 |
|
|
2019
Q4 | $1.4M | Buy |
79,393
+748
| +1% | +$12.7K | ﹤0.01% | 1244 |
|
|
2019
Q3 | $1.39M | Sell |
78,645
-1,226
| -2% | -$24.8K | ﹤0.01% | 1194 |
|
|
2019
Q2 | $1.71M | Buy |
79,871
+2,364
| +3% | +$49.5K | 0.01% | 1092 |
|
|
2019
Q1 | $1.84M | Buy |
77,507
+1,783
| +2% | +$40.7K | 0.01% | 1004 |
|
|
2018
Q4 | $1.49M | Sell |
75,724
-28,837
| -28% | -$514K | 0.01% | 961 |
|
|
2018
Q3 | $1.85M | Sell |
104,561
-18,586
| -15% | -$362K | 0.01% | 931 |
|
|
2018
Q2 | $2.65M | Buy |
+123,147
| New | +$2.55M | 0.01% | 811 |
|
Other funds holding EXEL
FCM
Thrivent Financial for Lutherans's EXEL Position: Q2 2026 in Review
Thrivent Financial for Lutherans increased its Exelixis (EXEL) stake by 3.3% in Q2 2026, buying an estimated $2.54M and bringing the position to 1,620,743 shares worth $88.2M. The position accounts for 0.15% of the portfolio, ranked #159.
Thrivent Financial for Lutherans first reported a position in EXEL in Q2 2018 and has held it in 33 quarters since. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Thrivent Financial for Lutherans held 1,620,743 shares of Exelixis worth $88.2M as of Q2 2026.
- Thrivent Financial for Lutherans bought 52,116 Exelixis shares in Q2 2026, an estimated $2.54M.
- Exelixis made up 0.15% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #159 holding.
- Thrivent Financial for Lutherans first reported a position in Exelixis in Q2 2018 and has held it in 33 quarters since.
- 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.